As you may know, the Federal Trade Commission recently requested public comments on the impacts of Pharmacy Benefit Managers’ practices, affecting drug affordability and access.

Today, RWC-340B submitted detailed comments to Commissioners Khan, Phillips, Slaughter, and Wilson, outlining the discriminatory practices faced by covered entities. Click here to read RWC-340B’s submission.

While these comments were presented on behalf of the entire RWC-340B Coalition, we encourage members to submit a comment as well. Click here to view the request and submit a comment. Per the FTC’s request, do not include any sensitive or confidential information, as comments are public.